Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Dr Muhammad Javaid
kassim.javaid@ndorms.ox.ac.uk


Zaineb Mohsin
zaineb.mohsin@ndorms.ox.ac.uk


Zaineb Mohsin
zaineb.mohsin@ndorms.ox.ac.uk


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Patient and staff experience of Fracture Liaison Services

Patient and staff experience of Fracture Liaison Services

Recruiting

Open to: Female / Male

Age: 50 Years - 99 Years

Medical Conditions

Disorders of bone density and structure


This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.


Each year,500,000 adults in the UK break a bone after a minor fall. For some patients,this could be the first sign of osteoporosis. Osteoporosis is a condition where bones become weakened and studies have shown that without treatment,the bones get weaker and are more likely to break again.
The NHS funds teams of doctors,nurses and other healthcare providers to work as a Fracture Liaison Service (FLS) to provide osteoporosis checks for patients after they have broken a bone. This is so patients identified as being at risk,can be started on treatment to prevent further broken bones.
It has been calculated that,in a population of 300,000 adults,an effective FLS will prevent around 250 fractures over 5 years,of which about 140 would be hip fractures. This is important,as it is estimated that one in 10 patients with a hip fracture are admitted to a care home rather than returning home. The total expected local savings to the NHS and social care of these prevented fractures is estimated at ÂŁ2.1 million over 5 years for a service cost of around ÂŁ640,000,a net benefit of ÂŁ1.46 million.
Currently,Fracture Liaison Services across the NHS work in different ways with a variable degree of performance. Due to this,it is estimated that each year,90,000 patients who should be on anti-osteoporosis therapy are not receiving it. This results in thousands of avoidable admissions for fractures,long term loss of independence and a higher risk of dying.
Key Performance Indicators (KPIs) are ways of measuring performance that show some FLSs are more “effective” than others in identifying,recommending treatment and ensuring patients stay on treatment. This study was designed to listen to patients and staff from “effective” and “ineffective” FLSs,to find out what helps or challenges them when they receive or deliver care. We will ask patients and staff what they think are the most important organisational factors that lead to the best care. We will also see if this leads to finding new organisational factors that may help improve the service.
The study will be rigorous in its approach to interviews and analysis. Interviews will be recorded and transcribed. Participants will be given a number so they cannot be identified,and data will be stored safely. Analysis will build on each individual interview to develop themes. These will reflect the experience of the participants. We will include a diverse range of participants,including men and adults who have Urdu as their first language. Privacy and dignity of the participants will be ensured.
Following individual interviews,we will explore the findings in a group discussion (focus group) to review any new organisational factors that should be included as KPIs.
The outcome of this research will be discussed with patient and public representatives. The results of this study will be published in journals,presented at conferences and circulated to patient and professional networks. This would help plan systematic changes within Fracture Liaison Services to help patients get better care.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

30 May 2024 30 Sep 2024

Observational

Observational type: Qualitative;



You can take part if:



You may not be able to take part if:


Participants may not enter the study if any of the following apply: • Unable to commit sufficient time for the interview. • Unable to participate in a telephone or digital audio/visual interview including the presence of significant hearing impairment.


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Bradford Royal Infirmary
    Duckworth Lane
    Bradford
    West Yorkshire
    BD9 6RJ
  • West Middlesex University Hospital
    Twickenham Road
    Isleworth
    Middlesex
    TW7 6AF
  • St Mary's Hospital (hq)
    Praed Street
    London
    Greater London
    W2 1NY
  • The James Cook University Hospital
    Marton Road
    Middlesbrough
    Cleveland
    TS4 3BW
  • Southmead Hospital
    Southmead Road
    westbury-on-trym
    Bristol
    Avon
    BS10 5NB
  • Bristol Royal Infirmary
    Marlborough Street
    Bristol
    Avon
    BS2 8HW
  • Ealing Hospital
    Uxbridge Road
    Southall
    Middlesex
    UB1 3HW


The study is sponsored by University of Oxford and funded by ROYAL OSTEOPOROSIS SOCIETY .




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details

for Trial ID: CPMS 61271

Last updated 21 November 2024

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.